Advanced Therapy Medicinal Products (ATMPs)

Bringing ATMPs closer to patients

ATMPs offer transformative potential for conditions once considered untreatable—ranging from cancer to neurodegenerative and cardiovascular diseases. At Pivotal, we help sponsors navigate the complex clinical and regulatory landscape of these innovative therapies.

Our specialised team provides end-to-end support across all trial phases, addressing the unique scientific, logistical, and compliance challenges of ATMPs development.

We understand the hurdles that delay progress—from manufacturing intricacies to regulatory requirements—and work with you to overcome them.

Partner with us to accelerate the development of ATMPs and deliver tomorrow’s therapies to the patients who need them today.

Our ATMP experience

Proven expertise across a range of cardiovascular indications.

Gene therapies for inherited and acquired diseases
Cell therapies, both autologous and allogeneic
Tissue-engineered products for regenerative medicine
Oncolytic viruses and other advanced immunotherapies

Our Solutions for Biotechs

We offer end-to-end clinical development solutions tailored to your needs. Whether you’re preparing for first-in-human or managing a global Phase 3 trial, our agile team delivers expertise, insight, and hands-on support at every stage.

Connect with us